And we both know that I’m in the black and you’re in the red.
That’s the best part.
You know that MSB was talking up doing an FDA P3 trial for OA a few years ago. It didn’t happen.
Right now, due to CYPs decision to do this OA trial in Australia, MSB is closer (time wise) for FDA approval for OA. By about 4 years by having not done anything.
You keep looking in the rear view mirror. It’s all just a waste of time and saliva. The future awaits - best not waste it if you can.
Stuart Robert's Pitt Street Report, page-102
-
- There are more pages in this discussion • 188 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.78M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.0¢ | $44.86K | 165.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24189 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 10983 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |